Skip to content
Search

Latest Stories

Pharmacy closures spell trouble for healthcare suppliers and patients

Pharmacy closures spell trouble for healthcare suppliers and patients

With more than 350 closures in the past year alone, patients are facing difficulties in collecting their prescriptions

The escalating number of pharmacy closures across the UK has set off alarm bells among healthcare professionals and industry stakeholders alike.


According to recent findings from the Company Chemists’ Association (CCA), the tally of operational community pharmacies within NHS England hit a dismal low of 11,414 during the financial year 2022/2023. This drop, fueled by a net loss of 388 pharmacies, marks the lowest figure since 2015/16.

The CCA report further reveals a distressing trend: the rate of net closures is accelerating, with an average of eight pharmacies shutting down every week. Compounding the issue, over a third of these closures—37.5 per cent—have occurred in England’s most economically disadvantaged areas.

These revelations underscore the urgent need for action within the pharmaceutical supply chain. As pharmacies vanish from the high street, suppliers and distributors are grappling with disrupted distribution networks and dwindling avenues for product placement.

The recent closure of Lloyds Pharmacy outlets, a fixture on many UK high streets, has sent shockwaves through the industry.

With more than 350 closures in the past year alone, including the shuttering of all 237 Lloyds branches housed within Sainsbury’s supermarkets, the move has left patients and suppliers alike in limbo.

CCA chief executive Malcolm Harrison expressed grave concern over the news, stating that it could potentially impact the accessibility of medicines.

He noted that the exit of such a major player should serve as a "wake-up call" to both the government and the NHS.

Highlighting that pharmacies presently dispense over one billion NHS medicines annually to patients, he remarked that the ongoing closure of pharmacies will further degrade access to medicines and other critical primary care services.

Meanwhile, patients have conveyed to The Telegraph that they have been facing difficulties in collecting their prescriptions because there was no pharmacist available to dispense them.

Additionally, the pharmacy-led health and beauty retailer, Boots, put out a list of pharmacies shutting down in the beginning of 2024 as it moves forward with its plan to close 300 stores.

As the healthcare landscape evolves, continued delivery of vital medical products and services to communities across the UK remains a cause of concern for both, pharmacies and patients alike.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less